Quidel获得奥利分类资产
Quidel Corporation,一种快速诊断检测解决方案,基于细胞病毒学测定和分子诊断系统的提供商,已进入最终协议,以获取分类仪片PRO心血管(CV)和毒理学资产(“分类业务”)和B型天赋Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”) from Alere Inc. These products are being divested in order to obtain antitrust approvals required for Abbott’s pending acquisition of Alere.